This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page | Contact Us | Sign In | Register
2017 Winter Meeting Agenda


Winter Meeting Detailed Program



Organizing Committee Members


Amy Roe, Procter & Gamble (Chair)
Laurie Haws, ToxStrategies, Inc. (Co-Chair)
A. Wallace Hayes, Harvard University & Michigan State University
Tetyana Kobets, New York Medical College
Todd Page, Eli Lilly & Co
Cynthia Rider, NIEHS-NTP


Detailed Program Schedule By Day


All Sessions and Breaks will be held in the Athens Ballroom. All Attendee Meals & Events will be held in the Paris Ballroom


Monday, February 6


8:15 AM–9:00 AM KEYNOTE LECTURE: Future of Precision Medicine
Luciana Borio, Acting Chief Scientist - US Food and Drug Administration
9:00 AM–12:30 PM SESSION: A Search for Biomarkers of Neurotoxicity: A Practical Approach
Moderated by Syed Imam & William Slikker
9:00 AM–9:30 AM Overview of the Biomarker Initiative to Identify Biological Fluid-Based Indicators of Neurotoxicity
Merle Paule, US FDA-NCTR
9:30 AM–10:00 AM Glial Fibrillary Acidic Protein (GFAP) and Related Astroglial Proteins as Biomarkers of Neurotoxicity
James O’Callaghan, CDC-NIOSH
10:00 AM–10:30 AM Lipidomics Approach to Understand TMT-Induced Neurotoxicity 
Andrea Armirotti, Istituto Italiano di Tecnologia
10:30 AM–11:00 AM BREAK
11:10 AM–11:30 AM Alterations in the Metabolome in CSF and Plasma May Provide Fluidic Biomarkers of CNS Toxicity 
11:30 AM–12:00 PM Oxidative Stress and Neuroinflammatory Biomarkers of Neurotoxicity: Correlation with Neuropathological Damage
Syed Imam, US FDA-NCTR
12:00 PM–12:30 PM Moderated Discussion
(Included with Registration) 
1:30 PM–5:15 PM SESSION: Observational Low-Dose Effects and Non-Monotonic Responses: Relevance for Research, Risk Assessment and Regulatory Decision-Making
Moderated by Daland Juberg & Suzanne Fitzpatrick
1:30 PM–2:00 PM A Grounding Amongst Stakeholders on the Need for Common Understanding of Definition and Problem Formulation
Kun Don Yi, Syngenta Crop Protection
2:00 PM–2:30 PM Biological Mechanisms Underlying Low-Dose and Nonmonotonic Effects
Mark Miller, NIEHS
2:30 PM–3:00 PM Some Experiences with LDNM Responses in Guideline Toxicity Studies
Sue Marty, Dow Chemical Company
3:00 PM–3:30 PM BREAK
3:30 PM–4:00 PM How the US EPA Uses LDNM in Risk Assessment
Stanley Barone, US EPA-OSCPP
4:00 PM–4:30 PM Points to Consider When Assessing Dose Response Data for Use in Safety Assessment
Janet Zang, US FDA-CFSAN
4:30 PM–5:15 PM Moderated Discussion
(Included with Registration) 


Tuesday, February 7


8:30 AM–12:00 PM SESSION: Evolution of the Mode of Action Framework: Building Confidence and Consistency
Moderated by Vicki Dellarco & A. Wallace Hayes
8:30 AM–9:00 AM Evolution of the Bradford Hill Considerations and Comparative Analysis of Weight of Evidence 
Alan Boobis, Imperial College London  
9:00 AM–9:30 AM

Importance of Integrating Mode of Action into a Regulatory Risk Assessment  
Jennifer Seed, US EPA (Retired) and Suzanne Fitzpatrick, US FDA-CFSAN

9:30 AM–10:00 AM Recent Experience and Challenges in Using MOA in Regulatory Application 
Bette Meek, University of Ottawa
10:00 AM–10:30 AM BREAK
10:30 AM–11:00 AM

A Method for Quantitative Scoring of Causality for Side-by Side Comparison of Confidence for Alternative MOAs (Including Case Examples)
Richard Becker, American Chemistry Council & Mary Ko Manibusan, Exponent

11:00 AM–11:30 AM Multisector Perspectives on the Application of the MOA Framework and the Remaining Scientific and Regulatory Challenges Ahead
Anna Lowit, US EPA  & Vincent Cogliano, US EPA & Reza Rasoulpour, Dow AgroSciences
11:30 AM–12:00 PM Moderated Discussion
12:00 PM–12:30 PM Philippe Shubik Award Lecture: Ah Receptor Ligands: Bad, Good or Both?
Stephen Safe, Texas A&M University 
(Included with Registration) 
1:30 PM–5:00 PM SESSION: From Assay to Assessment: Incorporating High Throughput Strategies into Health and Safety Evaluations
Moderated by Julia Rager & Reza Rasoulpour & Cynthia Rider
1:30 PM–1:55 PM Integration of High Content and High Throughput Screening Predictions to Inform Ongoing Metals Risk Assessment
Julia Rager, ToxStrategies
1:55 PM–2:20 PM Integrating Multiple Sources of High-Dimensional Data to Quantify Effects of Genetic Variability in Chemical Risk Assessment
David Reif, North Carolina State University
2:20 PM–2:45 PM Combining High Content Chemical and Biological Data to Determine Sufficient Similarity of Complex Botanical Mixtures 
Cynthia Rider, NIEHS-NTP  
2:45 PM–3:15 PM BREAK
3:15 PM–3:40 PM Building Scientific Confidence in Read-Across: Progress in Using HT/HC Data to Inform Read-Across Performance
Grace Patlewicz, US EPA-NCCT  
3:40 PM–4:05 PM Where the Rubber Meets the Road—Applications of High Throughput Screening for Product Safety Assessment
Reza Rasoulpour, Dow AgroSciences
4:05 PM–4:30 PM Application of In Vitro and High Throughput Screening in EPA Pesticide Risk Assessment: Recent Examples and Looking Forward
Anna Lowit, US EPA-OPP
4:30 PM–5:00 PM Moderated Discussion
(Included with Registration) 


Wednesday, February 8


A series of short topical presentations intended to start and build scientific dialogue  
8:30 AM–9:00 AM EPA Plan for TSCA-Reform Implementation
Jeff Morris, US EPA
9:00 AM–9:30 AM Need for Clear Regulation of Pesticide Residue Limits for Articles of Botanical Origin
Josef Brinckmann, Traditional Medicinals
9:30 AM–10:00 AM A Lite Approach to Tumor Mode of Action: Ready for Prime Time? 
Richard Peffer, Syngenta Crop Protection LLC
10:00 AM–1:30 PM SESSION: Emerging Insecticidal Proteins in Biotechnology: Evolution of the Safety Evaluation Framework
Moderated by Jay Petrick
10:00 AM–10:30 AM What Does a Toxicologist Need to Know About Proteins Introduced into GM Crops? 
Joseph Jez, Washington University in St. Louis
10:30 AM–11:00 AM Proteins for Insect Control: Pore-Forming Proteins 
Juan Luis Jurat-Fuentes, University of Tennessee
11:00 AM–11:30 AM BREAK
11:30 AM–12:00 PM Role of Protein Domains and Other Key Aspects of Protein Biology in Evaluating the Toxicity of New Proteins 
Scott McClain, Syngenta Crop Protection
12:00 PM–12:30 PM Regulatory Perspective on Evaluating Safety of Proteins for Insect Control  
John Kough, US EPA–Microbial Pesticides Branch
12:30 PM–1:00 PM Toxicological Assessment of β-Pore Forming Proteins for Insect Control
Jay Petrick, Monsanto
1:00 PM–1:30 PM Moderated Discussion